litlas
ログインアカウント作成

David A. Scheinberg

1982–2025 年に発表

110
論文数
20,888
被引用数
79
h 指数
110
i10 指数

被引用数

David A. Scheinberg の年別被引用数1983 年: 被引用 7 件1984 年: 被引用 8 件1985 年: 被引用 4 件1986 年: 被引用 5 件1987 年: 被引用 2 件1988 年: 被引用 3 件1989 年: 被引用 5 件1990 年: 被引用 6 件1991 年: 被引用 10 件1992 年: 被引用 42 件1993 年: 被引用 30 件1994 年: 被引用 18 件1995 年: 被引用 22 件1996 年: 被引用 14 件1997 年: 被引用 20 件1998 年: 被引用 28 件1999 年: 被引用 86 件2000 年: 被引用 85 件2001 年: 被引用 130 件2002 年: 被引用 126 件2003 年: 被引用 114 件2004 年: 被引用 147 件2005 年: 被引用 135 件2006 年: 被引用 87 件2007 年: 被引用 134 件2008 年: 被引用 151 件2009 年: 被引用 115 件2010 年: 被引用 153 件2011 年: 被引用 167 件2012 年: 被引用 162 件2013 年: 被引用 202 件2014 年: 被引用 138 件2015 年: 被引用 150 件2016 年: 被引用 173 件2017 年: 被引用 170 件2018 年: 被引用 260 件2019 年: 被引用 489 件2020 年: 被引用 621 件2021 年: 被引用 614 件2022 年: 被引用 445 件2023 年: 被引用 436 件2024 年: 被引用 572 件2025 年: 被引用 315 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,453 件、この内訳の 35.5%中国: 引用元論文 926 件、この内訳の 13.4%ドイツ: 引用元論文 384 件、この内訳の 5.6%イギリス: 引用元論文 362 件、この内訳の 5.2%イタリア: 引用元論文 252 件、この内訳の 3.6%フランス: 引用元論文 247 件、この内訳の 3.6%カナダ: 引用元論文 230 件、この内訳の 3.3%日本: 引用元論文 183 件、この内訳の 2.6%オランダ: 引用元論文 157 件、この内訳の 2.3%オーストラリア: 引用元論文 156 件、この内訳の 2.3%インド: 引用元論文 128 件、この内訳の 1.9%スペイン: 引用元論文 114 件、この内訳の 1.6%
0%35.5%その他 19.1%

機関

分野

  • Medicine57.2%
  • Biochemistry, Genetics and Molecular Biology24.5%
  • Immunology and Microbiology7.4%
  • Materials Science3.2%
  • Engineering1.8%
  • Health Professions1.1%
  • その他4.8%

トピック

  • CAR-T cell therapy research7.2%
  • Radiopharmaceutical Chemistry and Applications4.5%
  • Acute Myeloid Leukemia Research3.9%
  • Retinoids in leukemia and cellular processes3.8%
  • Immunotherapy and Immune Responses3.7%
  • Cancer Immunotherapy and Biomarkers3.2%
  • その他73.7%

共著者

全論文

検索で開く
  1. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

    著者: Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer, Ming Liu, Eliezer M. Van Allen, Guillermo de Velasco, Diana Miao, Irina Ostrovnaya, Esther Drill, Augustin Luna, Nils Weinhold, William Lee, Brandon J. Manley, Danny N. Khalil, Samuel D. Kaffenberger, Ying‐Bei Chen, Ludmila Danilova, Martin H. Voss, Jonathan Coleman, Paul Russo, Victor E. Reuter, Timothy A. Chan, Emily H. Cheng, David A. Scheinberg, Ming O. Li, Toni K. Choueiri, James J. Hsieh, Chris Sander, A. Ari Hakimi - Genome biology 2016 被引用: 1,042

  2. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

    著者: Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Marco L. Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Yvette Bernal, Hollie J. Pegram, Mark Przybylowski, Daniel Hollyman, Yelena Usachenko, Domenick Pirraglia, James Hosey, Elmer Santos, Elizabeth Halton, P. Maslak, David A. Scheinberg, Joseph G. Jurcic, Mark Heaney, Glenn Heller, Mark G. Frattini, Michel Sadelain - Blood 2011 被引用: 1,284

  3. Acute myeloid leukaemia

    著者: Asim Khwaja, Magnus Björkholm, Rosemary E. Gale, Ross L. Levine, Craig T. Jordan, Gerhard Ehninger, Clara D. Bloomfield, Eli Estey, Alan K. Burnett, Jan J. Cornelissen, David A. Scheinberg, Didier Bouscary, David C. Linch - Nature Reviews Disease Primers 2016 被引用: 587

  4. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    著者: Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff - Nature Medicine 2022 被引用: 129

  5. Engineering CAR-T cells to activate small-molecule drugs in situ

    著者: Thomas J. Gardner, J. Peter Lee, Christopher M. Bourne, Dinali Wijewarnasuriya, Nihar Kinarivala, Keifer G. Kurtz, Broderick C. Corless, Megan M. Dacek, Aaron Y. Chang, George Mo, Kha M. Nguyen, Renier J. Brentjens, Derek S. Tan, David A. Scheinberg - Nature Chemical Biology 2021 被引用: 77

  6. Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker

    著者: Megan M. Dacek, Keifer G. Kurtz, Patrick Wallisch, Stephanie Pierre, Shireen Khayat, Christopher M. Bourne, Thomas J. Gardner, Kristen Vogt, Nica Aquino, Anas Younes, David A. Scheinberg - Blood 2023 被引用: 46

  7. Tumor Therapy with Targeted Atomic Nanogenerators

    著者: Michael R. McDevitt, Dangshe Ma, Lawrence Lai, Jim Simón, Paul E. Borchardt, R. Keith Frank, Karen Wu, V Pellegrini, Michael Curcio, Matthias Miederer, Neil H. Bander, David A. Scheinberg - Science 2001 被引用: 504

  8. Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

    著者: Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia‐Yuan Ying, Chi-Shuen Chu, Man Chun John, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta J. Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, José Baselga, Anas Younes, Cassian Yee, Ahmet Doǧan, David A. Scheinberg, Robert G. Roeder, Ari Melnick, Michael R. Green - Cancer Discovery 2020 被引用: 159

  9. Paradoxical glomerular filtration of carbon nanotubes

    著者: Alessandro Ruggiero, Carlos H. Villa, Evan D. Bander, Diego A. Rey, Magnus Bergkvist, Carl A. Batt, Katia Manova‐Todorova, William M. Deen, David A. Scheinberg, Michael R. McDevitt - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 被引用: 418

  10. Rejection of immunogenic tumor clones is limited by clonal fraction

    著者: Ron S. Gejman, Aaron Y. Chang, Heather F. Jones, Krysta M. DiKun, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg - eLife 2018 被引用: 135

  11. Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells

    著者: Elliott J. Brea, Claire Y. Oh, Eusebio Manchado, Sadna Budhu, Ron S. Gejman, George Mo, Patrizia Mondello, James E. Han, Casey A. Jarvis, David Ulmert, Qing Xiang, Aaron Y. Chang, Ralph Garippa, Taha Merghoub, Jedd D. Wolchok, Neal Rosen, Scott W. Lowe, David A. Scheinberg - Cancer Immunology Research 2016 被引用: 176

  12. Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

    著者: P. Maslak, Tao Dao, Yvette Bernal, Suzanne Chanel, Rong Zhang, Mark G. Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit K. Rampal, Jae H. Park, Dan Douer, Laura M. Katz, Nicholas J. Sarlis, Martin S. Tallman, David A. Scheinberg - Blood Advances 2018 被引用: 159

  13. Alpha-Emitting Radionuclides: Current Status and Future Perspectives

    著者: Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A. Scheinberg, Michael R. McDevitt - Pharmaceuticals 2024 被引用: 55

  14. Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

    著者: Eric J. Feldman, Joseph Brandwein, Richard M. Stone, Matt Kalaycio, Joseph O. Moore, Julie O’Connor, Nancy Wedel, Gail J. Roboz, Carole B. Miller, Raj Chopra, Joseph C. Jurcic, Randy A. Brown, W. Christopher Ehmann, Philip Schulman, Stanley R. Frankel, Daniel De Angelo, David A. Scheinberg - Journal of Clinical Oncology 2005 被引用: 249

  15. Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

    著者: Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, Mythili Koneru, Tao Dao, C Liu, David A. Scheinberg, Renier J. Brentjens - Leukemia 2016 被引用: 150

  16. Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

    著者: Sung Soo Mun, Jeremy Meyerberg, Leila Peraro, Tatyana Korontsvit, Thomas J. Gardner, Manish Malviya, Chrisann Kyi, Roisin E. O’Cearbhaill, Liu C, Tao Dao, David A. Scheinberg - Cancer Immunology Immunotherapy 2023 被引用: 35

  17. Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

    著者: David A. Scheinberg, Michael R. McDevitt - Current Radiopharmaceuticals 2011 被引用: 177

  18. Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury

    著者: Simone Alidori, Nima Akhavein, Daniel L.J. Thorek, Katja Behling, Yevgeniy Romin, Dawn Queen, Bradley J. Beattie, Katia Manova‐Todorova, Magnus Bergkvist, David A. Scheinberg, Michael R. McDevitt - Science Translational Medicine 2016 被引用: 127

  19. Design and synthesis of 225Ac radioimmunopharmaceuticals

    著者: Michael R. McDevitt, Dangshe Ma, Jim Simón, R. Keith Frank, David A. Scheinberg - Applied Radiation and Isotopes 2002 被引用: 231

  20. Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

    著者: Matthias Miederer, David A. Scheinberg, Michael R. McDevitt - Advanced Drug Delivery Reviews 2008 被引用: 214

  21. Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab

    著者: Todd L. Rosenblat, Michael R. McDevitt, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Mark G. Frattini, Peter G. Maslak, Jae H. Park, Dan Douer, Dragan Cicic, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic - Clinical Cancer Research 2022 被引用: 63

  22. Challenges and solutions for therapeuticTCR‐based agents

    著者: Manish Malviya, Zita E. H. Aretz, Zaki Molvi, Jaeyop Lee, Stephanie Pierre, Patrick Wallisch, Tao Dao, David A. Scheinberg - Immunological Reviews 2023 被引用: 31

  23. Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

    著者: Todd Rosenblat, Michael R. McDevitt, Deborah Mulford, Neeta Pandit‐Taskar, Chaitanya Divgi, Katherine S. Panageas, Mark Heaney, Suzanne Chanel, Alfred Morgenstern, George Sgouros, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic - Clinical Cancer Research 2010 被引用: 264

  24. Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

    著者: Tao Dao, Su Yan, Nicholas Veomett, Dmitry Pankov, Liang Zhou, Tatyana Korontsvit, Andrew Scott, Joseph A. Whitten, P. Maslak, Emily Casey, Taochao Tan, Hong Liu, Victoria Zakhaleva, Michael Curcio, Ekaterina Doubrovina, Richard J. O’Reilly, Liu C, David A. Scheinberg - Science Translational Medicine 2013 被引用: 180